It's important to note that GLP-1 receptor agonists are generally not recommended for people with severe gastrointestinal disease or gastroparesis, as stated in their Summary of Product Characteristics (SmPCs)
Citations Farokhnia, M., et al, "Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake," Journal of Clinical Investigation, March 6, 2025, doi: 10.1172/JCI188314 Hendershot CS et al, "Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial." JAMA Psychiatry, Feb
2) Bloating or swelling in the abdomen
A decrease in body temperature is a normal metabolic response to eating less and losing weight, both of which often happen on semaglutide
With combined, dual acting appetite suppressing properties, our patients have found the most success